Start a FREE 2-WEEK TRIAL of Codify by AAPC.
This is a Proprietary Laboratory Analyses (PLA) code, meaning that the code applies to only one unique lab test made by a specific manufacturer or performed by a specific lab. Report 0645U only for FusionMRD™ Monitoring from Pairidex®. This test analyzes a blood or bone marrow sample to evaluate minimal residual disease (MRD), which means a small amount of cancer that may remain after treatment. The test focuses on rearrangements and uses digital polymerase chain reaction (PCR). The results are reported as not detected or detected with estimated abundance.
For clinical responsibility, terminology, tips and additional info
start codify free trial.